Article
Fourteen composite probiotics alleviate type 2 diabetes through modulating gut microbiota and modifying M1/M2 phenotype macrophage in db/db mice.
Pharmacological research - 1 Nov 2020
Wang Yanming, Wu Yuche, Sailike Jialehasibieke, Sun Xin, Abuduwaili Nigare, Tuoliuhan Hapula, Yusufu Mulatiaize, Nabi Xin-Hua
Abstract excerpt
Dysregulation of intestinal microbiota accelerates the development of type 2 diabetes. Probiotics are potential adjunctive therapy in the treatment of diabetes. This study investigated the anti-diabetic mechanism of 14 composite probiotics. Results showed that treatment with 14 composite probiotics improved intestinal microbiota equilibrium by increasing the population of short-chain fatty acids (SCFAs)-producing...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
